|
Jan 04, 2025
|
|
|
|
RSCI 606 Regulation of Emerging Technologies and Biological Products Units: 3 Policies, testing and regulatory requirements affecting commercialization of biologics and novel medical technologies. Focus on biologics, blood and tissue products, radiopharmaceuticals and nanotechnology. Instruction Mode: Lecture Grading Option: Letter
|
|
You must be logged in to post a comment.